Patients are searching for this trial right now

This page is already ranking on Google. Activate it to start receiving pre-qualified patient leads directly in your inbox.

14-day free trial · $44/mo after · Cancel anytime · Money-back guarantee

NCT05065151 · University of California, San Francisco

Understanding Motivation in Parkinson's Patients Through Neurophysiology

(MPPN)

What this study is about

The study aims to better understand motivation and value-based decision-making in Parkinson's patients through neurophysiology using Medtronic's Percept DBS device. By combining behavioral tasks with neural recordings, the study seeks to uncover how DBS affects motivation, particularly in relation to effort, reward, and timing.

View original scientific description

The study aims to better understand motivation and value-based decision-making in Parkinson's patients through neurophysiology using Medtronic's Percept DBS device. By combining behavioral tasks with neural recordings, the study seeks to uncover how DBS affects motivation, particularly in relation to effort, reward, and timing.

Interventions

OTHER

Stimulation on

Stimulation from Percept DBS will be on while the patient is playing a decision-making game on a computer-based application.

OTHER

Stimulation off

Stimulation from Percept DBS will be off while the patient is playing a decision-making game on a computer-based application.

BEHAVIORAL

Decision Making Task

Patients will be playing a decision making task through a computer-based application.

Primary outcome measures

Percent of Risky Decisions made with Percept DBS stimulation on for Parkinson's Disease Patients

Time frame: The values will be collected starting from admission in clinic and the at-home paradigm. Data collection and analysis of said values can take up to three years

Patients' responses on the tablet will be recorded in-clinic and at home. The investigators will tally their choices from the value-based decision making game (risky versus safe decisions) and report an average of risky responses.

Percent of Risky Decisions made with Percept DBS stimulation off for Parkinson's Disease Patients

Time frame: The values will be collected starting from admission in clinic and the at-home paradigm. Data collection and analysis of said values can take up to three years

Patients' responses on the tablet will be recorded in-clinic and at home. The investigators will tally their choices from the value-based decision making game (risky versus safe decisions) and report an average of risky responses.

Reaction Time During Decision-Making Task

Time frame: The values will be collected starting from admission in clinic. Data collection and analysis of said values can take up to three years.

The investigators will measure the time it takes for patients to make each decision on the value-based decision-making task in the clinic.

Task Success Rate

Time frame: The values will be collected starting from admission in clinic. Data collection and analysis of said values can take up to three years.

The investigators will calculate the percentage of trials in which patients complete the task successfully according to predefined task performance criteria.

Acceptance Rate of Risky Versus Safe Options

Time frame: The values will be collected starting from admission in clinic. Data collection and analysis of said values can take up to three years.

The proportion of trials where patients accept risky versus safe options will be calculated and compared across stimulation ON and OFF conditions.

Force Exertion During Motor Responses

Time frame: The values will be collected starting from admission in clinic. Data collection and analysis of said values can take up to three years.

Force data will be recorded during motor responses to evaluate physical engagement and motor control during task performance.

Low frequency local field potentials

Time frame: The values will be collected starting from admission in clinic. Data collection and analysis of said values can take up to three years.

Local field potentials (LFPs) will be recorded from the implanted Percept device to evaluate neural activity during decision making under different stimulation conditions. Low frequency power will be calculated during specific time intervals during the task. Cardiac artifact will be removed with electrocardiogram (ECG) measurements recorded during the same task.

Electroencephalogram (EEG) theta band power

Time frame: The values will be collected starting from admission in clinic. Data collection and analysis of said values can take up to three years.

Scalp EEG will be recorded concurrently with task performance to assess cortical activity patterns during decision-making. Average theta band power will be calculated in specific time intervals during the task.

Electroencephalogram (EEG) beta band power

Time frame: The values will be collected starting from admission in clinic. Data collection and analysis of said values can take up to three years.

Scalp EEG will be recorded concurrently with task performance to assess cortical activity patterns during decision-making. Average beta band power will be calculated in specific time intervals during the task.

Electroencephalogram (EEG) gamma band power

Time frame: The values will be collected starting from admission in clinic. Data collection and analysis of said values can take up to three years.

Scalp EEG will be recorded concurrently with task performance to assess cortical activity patterns during decision-making. Average gamma band power will be calculated in specific time intervals during the task.

Electroencephalogram (EEG) alpha band power

Time frame: The values will be collected starting from admission in clinic. Data collection and analysis of said values can take up to three years.

Scalp EEG will be recorded concurrently with task performance to assess cortical activity patterns during decision-making. Average alpha band power will be calculated in specific time intervals during the task.

Who can participate

This study lists these criteria on ClinicalTrials.gov. A study coordinator reviews eligibility during screening — this page does not determine whether you qualify.

Inclusion criteria

  • Has Parkinson's Disease or Dystonia
  • Has Medtronic Percept or RC+S DBS device implanted in either GPI or STN
  • Has DBS device implanted either bilaterally or unilaterally
  • Male or female
  • More than 1 month post-DBS surgery

Exclusion criteria

  • Severe cognitive impairments
  • Has MOCA score below 20
  • Age less than 18 years old

Where

  • San Francisco, California

Collaborators

Yale University, Rune Labs, University of Birmingham

Related conditions & keywords

Parkinson DiseaseDeep Brain StimulationMotivationParkinson'sMedtronicPerceptDBSParkinson's DiseasePDReward-based decision makingTask

Frequently asked questions

What is a clinical trial?

A clinical trial is a research study that tests new medical treatments, drugs, devices, or procedures to determine their safety and effectiveness. Trials are carefully designed and monitored to protect participants while advancing medical knowledge.

Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. Trials must be reviewed and approved, and participants are closely monitored by medical professionals throughout the study. You can withdraw at any time if you choose.

Will I be compensated?

Many clinical trials offer compensation for your time, travel expenses, and inconvenience. The specific compensation varies by study and will be discussed during the screening process. All study-related medical care is typically provided at no cost to participants.

Will I receive a placebo instead of treatment?

When effective treatment exists, participants typically receive either the standard treatment plus the study intervention, or the standard treatment plus placebo. You would not be denied effective care. Placebos are primarily used when no proven treatment is available, or in addition to standard care. Your trial consent form will clearly explain what treatments you may receive.

Can I leave a trial if I change my mind?

Absolutely. Participation in clinical trials is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty or loss of benefits to which you are otherwise entitled.

How long does a clinical trial last?

Trial duration varies widely depending on the study design and purpose. Some trials last just a few weeks, while others may continue for months or years. The study coordinator will provide specific timeline information during your screening call.

Data: ClinicalTrials.gov · synced Jun 5, 2026 · Source of record for eligibility and locations

📊
1 of 70 participants interested
1% interest

See if this study fits

A short prescreen based on this study's listed criteria. A coordinator confirms eligibility — this is not a medical assessment.

Preparing your pre-screening questions…

Study locations

Choose your preferred location, or select flexible during enrollment.

RECRUITING

San Francisco

California

Location available

Express your interest

Share your contact details and a study coordinator can follow up about screening.

Secure & Confidential

Your information is protected and will only be shared with the research team.

What participation can include

  • Study-related care provided by the research team
  • Close monitoring by medical professionals
  • Possible compensation for time and travel*
  • The option to withdraw at any time
  • Contributing to medical research that may help future patients

*Compensation varies by study. Confirm details with coordinator.

Typical next steps

  1. 1.Submit this form
  2. 2.Phone screening
  3. 3.In-person assessment if eligible
  4. 4.Begin participation

Find More Parkinsons Disease Trials by City

Browse all parkinsons disease clinical trials in these cities — not just this study.

Looking for Parkinson Disease Treatment in San Francisco?

Join others in California exploring innovative treatment options through clinical research

Parkinson Disease Treatment Options in San Francisco, California

If you're searching for Parkinson Disease treatment in San Francisco, participating in a clinical research study may provide access to innovative approaches under expert medical supervision. This study is actively recruiting participants in San Francisco and surrounding areas.

Clinical trials offer participants the opportunity to receive cutting-edge treatments while contributing to medical research that may help future patients with Parkinson Disease. All study-related care is provided at no cost to participants.

Local Sites
1 locations in California
Now Enrolling
Up to 70 participants
Quick Start
Screening available now

Why Consider a Clinical Trial for Parkinson Disease?

Potential Benefits

  • Access to new treatment approaches before public availability
  • Close monitoring by experienced medical professionals
  • Study-related care provided at no cost
  • Contribute to medical research for Parkinson Disease

What to Expect

  • Initial screening to determine eligibility
  • Regular check-ups and monitoring visits
  • Possible compensation for time and travel
  • You can withdraw at any time

Frequently Asked Questions About This Parkinson Disease Study

Important Clinical Trial Information

This information is provided for educational purposes and does not constitute medical advice. Clinical trial participation involves potential risks and benefits. Eligibility requirements apply and will be assessed during the screening process.

Study identifier: NCT05065151. For complete study details, visit ClinicalTrials.gov. Always consult with your healthcare provider before making decisions about your medical care or participating in clinical research.